Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G May

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1992
Cimetidine-carbaryl interaction in humans: evidence for an active metabolite of carbarylD G May, R J Naukam, J R Kambam, et al.
Journal of Toxicology. Clinical Toxicology|January 1, 1988
Carbaryl metabolism is inhibited by cimetidine in the isolated perfused rat liver and in manS A Ward, D G May, A J Heath, et al.
Clinical Pharmacology and Therapeutics|December 1, 1990
The contribution of N-hydroxylation and acetylation to dapsone pharmacokinetics in normal subjectsD G May, J A Porter, J P Uetrecht, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1987
Vancomycin entry into lung lymph in sheepD G May, C W Stratton, W D Denney, et al.
Clinical Pharmacology and Therapeutics|June 1, 1992
The disposition of dapsone in cirrhosisD G May, P A Arns, W O Richards, et al.
Clinical Pharmacology and Therapeutics|September 1, 1990
Scleroderma is associated with differences in individual routes of drug metabolism: a study with dapsone, debrisoquin, and mephenytoinD G May, C M Black, N J Olsen, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1992
Cimetidine-carbaryl interaction in humans: evidence for an active metabolite of carbarylD G May, R J Naukam, J R Kambam, et al.
Journal of Toxicology. Clinical Toxicology|January 1, 1988
Carbaryl metabolism is inhibited by cimetidine in the isolated perfused rat liver and in manS A Ward, D G May, A J Heath, et al.
Clinical Pharmacology and Therapeutics|December 1, 1990
The contribution of N-hydroxylation and acetylation to dapsone pharmacokinetics in normal subjectsD G May, J A Porter, J P Uetrecht, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1987
Vancomycin entry into lung lymph in sheepD G May, C W Stratton, W D Denney, et al.
Clinical Pharmacology and Therapeutics|June 1, 1992
The disposition of dapsone in cirrhosisD G May, P A Arns, W O Richards, et al.
Clinical Pharmacology and Therapeutics|September 1, 1990
Scleroderma is associated with differences in individual routes of drug metabolism: a study with dapsone, debrisoquin, and mephenytoinD G May, C M Black, N J Olsen, et al.
Pageof 2